Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-16-001322
Filing Date
2016-03-17
Accepted
2016-03-17 16:13:04
Documents
2
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT, LLCCORMORANT GLOBAL HEALTHCARE GP, LLC

Document Format Files

Seq Description Document Type Size
1 sch13g.htm SC 13G 86870
2 ex1.htm EX-1 5111
  Complete submission text file 0000929638-16-001322.txt   93802
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Subject) CIK: 0001157602 (see all company filings)

EIN.: 043567753 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88337 | Film No.: 161512688
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Filed by) CIK: 0001618442 (see all company filings)

EIN.: 981101801 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G